Clinical Trials Mix Vaccine Types to Boost COVID Protection,

In fact, the heterologous prime-boost concept has been used in HIV trials for 25 years, said John Moore, PhD, from Weill Cornell Medical College in …, In fact, the heterologous prime-boost concept has been used in HIV trials for 25 years, said John Moore, PhD, from Weill Cornell Medical College in …, Read More

Scroll to Top